Brivudine

溴夫定

Report date: 2022/12/07 17:52:24
NME

Base Information

Drug NameBrivudine
Drug Alias NameBromovinyldeoxyuridine溴呋啶brivudinumbrivudinebrivudina +[11] 
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionDNA-directed DNA polymerase inhibitors
TargetsDNA-directed DNA polymerase
Therapy Area/IndicationsDry Eye SyndromesHerpes Zoster
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryHungaryAustriaGermany +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesRedwood Pharma Ab
China Registration ClassN/A

Develop Information

Active CompaniesBerlin-Chemie Ag (Menarini Group)
Inactive CompaniesRedwood Pharma Ab
Active IndicationsHerpes Zoster
Inactive IndicationsDry Eye Syndromes

Other Information

ATC CodeJ05AB15
Related LinksWikipediaKEGG